In vitro strategy for biocompatibility testing of medical devices: ISO's perspective on irritation and sensitization

被引：0
|
作者：
Pellevoisin, C. [1 ]
Coleman, K. [2 ]
De Jong, W. H. [3 ]
机构：
[1] EPISKIN, Lyon, France
[2] Medtronic Plc, Minneapolis, MN USA
[3] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands
来源：
TOXICOLOGY LETTERS | 2021年 / 350卷
关键词：
D O I：
暂无
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
P04-11
引用
收藏
页码：S92 / S93
页数：2
相关论文
共 50 条
  • [41] Development and performance of a biomimetic artificial perilymph for in vitro testing of medical devices
    Palmer, J. C.
    Green, R. A.
    Boscher, F.
    Poole-Warren, L. A.
    Carter, P. M.
    Enke, Y. L.
    Lovell, N. H.
    Lord, M. S.
    JOURNAL OF NEURAL ENGINEERING, 2019, 16 (02)
  • [42] Established cell lines and primary cultures in testing medical devices in vitro
    Cenni, E
    Ciapetti, G
    Granchi, D
    Arciola, CR
    Savarino, L
    Stea, S
    Montanaro, L
    Pizzoferrato, A
    TOXICOLOGY IN VITRO, 1999, 13 (4-5) : 801 - 810
  • [43] Novel cytokine marker available for skin irritation testing of medical devices using reconstructed human epidermis models
    Kato, Reiko
    Miyajima, Atsuko
    Komoriya, Kaoru
    Haishima, Yuji
    TOXICOLOGY IN VITRO, 2020, 68
  • [44] The "Big Three" in biocompatibility testing of medical devices: implementation of alternatives to animal experimentation-are we there yet?
    Kandarova, Helena
    Pobis, Peter
    FRONTIERS IN TOXICOLOGY, 2024, 5
  • [45] Round robin study to evaluate the Reconstructed Human Epidermis model as an in vitro skin irritation test for medical devices
    Coleman, Kelly
    De Jong, Wim
    Hoffmann, Sebastian
    Lee, Michelle
    Kandarova, Helena
    Letasiova, Silvia
    De La Fonteyne, Liset
    Pellevoisin, Christian
    Tornier, Carine
    Videau, Cristelle
    Haishima, Yuji
    Zdawczyk, Austin
    Turley, Audrey
    Willoughby, Jamin
    Bachelor, Michael
    Rollins, Beau
    TOXICOLOGY LETTERS, 2017, 280 : S278 - S278
  • [46] Biocompatibility of polymer-based biomaterials and medical devices - regulations, in vitro screening and risk-management
    Bernard, Melisande
    Jubeli, Emile
    Pungente, Michael D.
    Yagoubi, Najet
    BIOMATERIALS SCIENCE, 2018, 6 (08) : 2025 - 2053
  • [47] A ready-to-use integrated in vitro skin corrosion and irritation testing strategy using EpiSkin™ model in China
    Liu, Yanfeng
    Li, Nan
    Chen, Lizao
    Alepee, Nathalie
    Cai, Zhenzi
    TOXICOLOGY IN VITRO, 2020, 65
  • [48] Development of a novel in vitro respiratory sensitization assay and its application in an integrated testing strategy (ITS)
    Han, Yubin
    Kim, Hyeon Young
    Kim, Ha Ryong
    ARCHIVES OF TOXICOLOGY, 2025, 99 (02) : 775 - 785
  • [49] Postmarket surveillance for medical devices: America's new strategy
    Normand, Sharon-Lise T.
    Hatfield, Laura
    Drozda, Joseph
    Resnic, Frederic S.
    BRITISH MEDICAL JOURNAL, 2012, 345
  • [50] UNDERSTANDING ECONOMIC MODELS IN MEDICAL DEVICES: AN ORGANIZATION'S PERSPECTIVE
    Basu, R.
    Chien, H.
    Alsumali, A.
    VALUE IN HEALTH, 2018, 21 : S174 - S174
12345